# OnCo record paper-abc-06-folfox-second-line-lancet-oncol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-abc-06-folfox-second-line-lancet-oncol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-abc-06-folfox-second-line-lancet-oncol-2021" ;
  schema:name "Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial"@en ;
  schema:description "The UK trial that showed a second chemotherapy, FOLFOX, helps people with advanced bile duct or gallbladder cancer live about a month longer on average once gemcitabine and cisplatin stop working, with one in four alive at a year instead of one in nine."@en ;
  schema:url <https://onco.cc/key-papers/paper-abc-06-folfox-second-line-lancet-oncol-2021/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(21)00027-9>, <https://pubmed.ncbi.nlm.nih.gov/33798493/>, <https://clinicaltrials.gov/study/NCT01926236> ;
  onco:tag "gallbladder-evidence" ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(21)00027-9> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Lamarca A, Palmer DH, Wasan HS, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:drugs <https://onco.cc/drugs/folfox/> ;
  onco:institutions <https://onco.cc/institutions/the-christie/> ;
  onco:terms <https://onco.cc/terms/os/> ;
  onco:trials <https://onco.cc/trials/abc-06/> ;
  onco:people <https://onco.cc/people/angela-lamarca/>, <https://onco.cc/people/juan-valle/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .